Vascular Medicine

  • Bioresorbable stents: The future of interventional cardiology?
    Stephen G. Ellis, MD and Haris Riaz, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11 suppl 2) S18-S23; DOI: https://doi.org/10.3949/ccjm.83.s2.03
  • PCSK9 inhibition: A promise fulfilled?
    Khendi White, MD, Chaitra Mohan, MD and Michael Rocco, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11 suppl 2) S36-S44; DOI: https://doi.org/10.3949/ccjm.83.s2.05
  • Fibromuscular dysplasia: Advances in understanding and management
    Ellen K. Brinza, MS and Heather L. Gornik, MD
    Cleveland Clinic Journal of Medicine November 2016, 83 (11 suppl 2) S45-S51; DOI: https://doi.org/10.3949/ccjm.83.s2.06
  • There may be zebras running with the horses
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2016, 83 (10) 697-702; DOI: https://doi.org/10.3949/ccjm.83b.10016

    Common diseases are indeed common, but patients with less-common ones do fi nd their way into our practices.

  • Nonatherosclerotic limb ischemia: Prompt evaluation and diagnosis
    Nonatherosclerotic limb ischemia: Prompt evaluation and diagnosis
    John C. Eun, MD, William R. Hiatt, MD and Natalia O. Glebova, MD, PhD
    Cleveland Clinic Journal of Medicine October 2016, 83 (10) 741-751; DOI: https://doi.org/10.3949/ccjm.83a.15102

    Symptoms of ischemia may be difficult to recognize in younger patients, thus delaying diagnosis.

  • Should patients with stable ischemic heart disease undergo revascularization?
    Michael Chenier, MD, MPH and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 567-570; DOI: https://doi.org/10.3949/ccjm.83a.15093

    The benefi t is much less clear for stable disease than for acute coronary syndromes.

  • Thrombotic thrombocytopenic purpura: The role of ADAMTS13
    Heesun J. Rogers, MD, PhD, Charles Allen, DO and Alan E. Lichtin, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 597-603; DOI: https://doi.org/10.3949/ccjm.83a.15009

    ADAMTS13 testing is useful in diagnosing this disease, guiding therapy, and predicting relapse.

  • Anticoagulation in dental surgery: Is it rude to interrupt?
    Michael J. Wahl, DDS
    Cleveland Clinic Journal of Medicine June 2016, 83 (6) 409-413; DOI: https://doi.org/10.3949/ccjm.83a.15014

    Anticoagulation should not be interrupted for dental surgery.

  • Predicting is tough, especially about the future
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 2016, 83 (5) 324; DOI: https://doi.org/10.3949/ccjm.83b.05016

    All risk calculators—not just for anticoagulation—are based on the “average” patient. And no patient is average.

  • How can I predict bleeding in my elderly patient taking anticoagulants?
    Gene R. Quinn, MD, MS and Margaret C. Fang, MD, MPH
    Cleveland Clinic Journal of Medicine May 2016, 83 (5) 345-348; DOI: https://doi.org/10.3949/ccjm.83a.15002

    We have tools, but their predictive value is modest. Clinical judgment is important.

Pages